RECRUITING

Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study investigates the well-being and health-related quality of life in cancer patients and survivors during the COVID-19 pandemic. Using questionnaires may help researchers gain an understanding of how experiences during the COVID-19 pandemic (e.g., exposure, risk factors, testing, isolation, seropositivity, hospitalization, loss of family or friends, loss of income), may impact multiple domains of health-related quality of life (physical, emotional and social well-being), and other areas such as COVID-19-specific psychological distress (e.g., fear, anxiety and depressive symptoms), and disruptions to health care, finances, and social interactions.

Official Title

Well-Being and Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic

Quick Facts

Study Start:2020-06-11
Study Completion:2025-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04500600

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * MD Anderson active patient (visit within past 5 years)
  2. * ICD-10 confirmed cancer diagnosis
  3. * Documentation of being alive per the cancer registry
  4. * Patients who have signed consent for one of the following protocols: PA14-0241 or LAB03-0320
  5. * Has an active email address and/or can be contacted via MyChart
  6. * English or Spanish speaker
  1. * Non-active patient (i.e., no visit within past 5 years)
  2. * Language other than English or Spanish
  3. * Patients who have previously consented to the following protocols: 2012-0112, 2009-0976, 2005-0035, or PA15-0336, because they will be contacted through separate IRB protocols to complete this same survey

Contacts and Locations

Study Contact

Lorenzo Cohen
CONTACT
(713) 745-4260
lcohen@mdanderson.org

Principal Investigator

Lorenzo Cohen
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Lorenzo Cohen, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-06-11
Study Completion Date2025-04-30

Study Record Updates

Study Start Date2020-06-11
Study Completion Date2025-04-30

Terms related to this study

Additional Relevant MeSH Terms

  • COVID-19 Infection
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm